Chiesi Farmaceutici S.p.A. based in Parma, IT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-06-11

US20260159483A1

Chemistry; metallurgy

PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR

#2 | 2026-05-28

US20260144779A1

Human necessities

MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE

#3 | 2026-04-02

US20260092090A1

Chemistry; metallurgy

PRODUCTION OF NERVE GROWTH FACTOR (NGF) AND OF MUTEINS THEREOF

#4 | 2026-04-02

US20260090986A1

Human necessities

CAPSULE INHALER FOR THE ADMINISTRATION OF A PHOSPHODIESTERASE-4 INHIBITOR

#5 | 2026-03-26

US20260085077A1

Chemistry; metallurgy

HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS

#6 | 2026-03-26

US20260083924A1

Human necessities

CAPSULE INHALER FOR THE ADMINISTRATION OF A PHOSPHODIESTERASE-4 INHIBITOR

#7 | 2026-03-26

US20260083711A1

Human necessities

CAPSULE INHALER FOR THE ADMINISTRATION OF A PHOSPHODIESTERASE-4 INHIBITOR

#8 | 2026-01-29

US20260028328A1

Chemistry; metallurgy

HETEROARYL DERIVATIVES AS DDRs INHIBITORS

#9 | 2025-12-04

US20250368650A1

Chemistry; metallurgy

5-(4-FLUOROPHENYL)-2,3-DIHYDRO-1H-IMIDAZO[1,2-A]IMIDAZOLE DERIVATIVES AS ALK INHIBITORS FOR THE TREATMENT OF FIBROSIS

#10 | 2025-10-09

US20250312274A1

Human necessities

A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER

#11 | 2025-10-02

US20250302742A1

Human necessities

A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER

#12 | 2025-09-18

US20250288568A1

Human necessities

NEW CRYSTAL FORM OF A PDE4 INHIBITOR

#13 | 2025-08-28

US20250270215A1

Chemistry; metallurgy

IMIDAZOLE DERIVATIVES AS ALK5 INHIBITORS

#14 | 2025-08-07

US20250250232A1

Chemistry; metallurgy

AZETIDINE DERIVATIVES AND USE THEREOF AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS

#15 | 2025-07-17

US20250228948A1

Human necessities

METHODS OF TREATING OR PREVENTING STENT THROMBOSIS

#16 | 2025-07-03

US20250213540A1

Human necessities

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING LOW IMPURITY CONCENTRATIONS OF THE SAME

#17 | 2025-06-12

US20250188068A1

Chemistry; metallurgy

AMIDO CYCLOPROPYL DERIVATIVES AS LPA RECEPTOR INHIBITORS

#18 | 2025-03-27

US20250100997A1

Chemistry; metallurgy

PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS

#19 | 2025-02-27

US20250066341A1

Chemistry; metallurgy

CYCLOHEXANE ACID DERIVATIVES AS LPA RECEPTOR INHIBITORS

#20 | 2025-02-20

US20250059195A1

Chemistry; metallurgy

TRIAZOLONE DERIVATIVE SALT AS NEUTROPHIL ELASTASE INHIBITOR

#21 | 2025-02-20

US20250057825A1

Human necessities

CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS

#22 | 2025-02-13

US20250051340A1

Chemistry; metallurgy

TRIAZOLONE DERIVATIVE SALT AS NEUTROPHIL ELASTASE INHIBITOR

#23 | 2025-01-09

US20250011299A1

Chemistry; metallurgy

PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS

#24 | 2024-12-26

US20240425482A1

Chemistry; metallurgy

PYRROLIDINE DERIVATIVES AS DDRS INHIBITORS

#25 | 2024-11-28

US20240391936A1

Chemistry; metallurgy

TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS

#26 | 2024-11-07

US20240366682A1

Human necessities

PROCESS FOR THE PREPARATION OF A PULMONARY SURFACTANT

#27 | 2024-10-24

US20240350638A1

Human necessities

METHODS OF TREATING OR PREVENTING STENT THROMBOSIS

#28 | 2024-10-17 ✅ Patent 12,502,400 granted on 2025-12-23

US20240342205A1

Human necessities

METHOD OF PREVENTING OF SYSTEMIC-TO-PULMONARY-ARTERY SHUNT THROMBOSIS

#29 | 2024-08-22

US20240279240A1

Chemistry; metallurgy

HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS

#30 | 2024-07-04

US20240217967A1

Chemistry; metallurgy

INDOLINE DERIVATIVES AS DDRS INHIBITORS

#31 | 2024-06-20 ✅ Patent 12,617,801 granted on 2026-05-05

US20240199635A1

Chemistry; metallurgy

TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS

#32 | 2024-06-13

US20240190891A1

Chemistry; metallurgy

PYRIDO OXAZINE AMINO DERIVATIVES AS ALK5 INHIBITORS

#33 | 2024-06-13

US20240190847A1

Chemistry; metallurgy

INDOLINE DERIVATIVES AS DDR1 AND DDR2 INHIBITORS

#34 | 2024-05-23

US20240166651A1

Chemistry; metallurgy

HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS

#35 | 2024-05-23

US20240166605A1

Chemistry; metallurgy

PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR

#36 | 2024-05-23

US20240165203A1

Human necessities

COMBINED TREATMENT OF BRAIN INJURY

#37 | 2024-04-11

US20240116948A1

Chemistry; metallurgy

PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS

#38 | 2024-04-11

US20240116947A1

Chemistry; metallurgy

PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS

#39 | 2024-03-21 ✅ Patent 12,534,474 granted on 2026-01-27

US20240092792A1

Chemistry; metallurgy

DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS

#40 | 2024-03-21

US20240092791A1

Chemistry; metallurgy

DIHYDROFUROPYRIDINE DERIVATIVES AS RHO-KINASE INHIBITORS

#41 | 2024-03-21

US20240092790A1

Chemistry; metallurgy

DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS

#42 | 2024-03-14

US20240082223A1

Human necessities

DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS

#43 | 2024-01-25

US20240025880A1

Chemistry; metallurgy

AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS

#44 | 2024-01-18 ✅ Patent 12,479,826 granted on 2025-11-25

US20240018122A1

Chemistry; metallurgy

PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS

#45 | 2024-01-04 ✅ Patent 12,534,455 granted on 2026-01-27

US20240002371A1

Chemistry; metallurgy

PHTHALAZINE DERIVATIVES AS P2X3 INHIBITORS

#46 | 2023-12-28

US20230416233A1

Chemistry; metallurgy

(AZA)QUINOLINE 4-AMINES DERIVATIVES AS P2X3 INHIBITORS

#47 | 2023-11-16

US20230364015A1

Human necessities

PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES

#48 | 2023-10-12 ✅ Patent 12,016,851 granted on 2024-06-25

US20230321061A1

Human necessities

Modified release pharmaceutical formulations comprising deferiprone

#49 | 2023-10-12 ✅ Patent 12,016,850 granted on 2024-06-25

US20230321060A1

Human necessities

Modified release pharmaceutical formulations comprising deferiprone

#50 | 2023-09-07

US20230277451A1

Human necessities

A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER

#51 | 2023-08-17 ✅ Patent 12,606,609 granted on 2026-04-21

US20230257446A1

Chemistry; metallurgy

POLYPEPTIDES HAVING IMPROVED PROPERTIES

#52 | 2023-08-10 ✅ Patent 12,454,530 granted on 2025-10-28

US20230250093A1

Chemistry; metallurgy

AMIDO CYCLOHEXANE ACID DERIVATIVES AS LPA RECEPTOR INHIBITORS

#53 | 2023-07-20

US20230227447A1

Chemistry; metallurgy

BENZYLAMINE DERIVATIVES AS DDRS INHIBITORS

#54 | 2023-07-06 ✅ Patent 12,606,562 granted on 2026-04-21

US20230212169A9

Chemistry; metallurgy

PYRIDOPYRIMIDINES DERIVATIVES AS P2X3 INHIBITORS

#55 | 2023-05-25 ✅ Patent 12,357,568 granted on 2025-07-15

US20230157951A1

Human necessities

AEROSOL FORMULATION FOR COPD

#56 | 2023-05-11 ✅ Patent 12,383,507 granted on 2025-08-12

US20230145206A1

Human necessities

CLEVIDIPINE NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF

#57 | 2023-03-23 ✅ Patent 12,637,451 granted on 2026-05-26

US20230092892A1

Chemistry; metallurgy

AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS

#58 | 2023-03-02 ✅ Patent 12,404,270 granted on 2025-09-02

US20230063121A1

Chemistry; metallurgy

QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS

#59 | 2023-01-05 ✅ Patent 11,660,409 granted on 2023-05-30

US20230001111A1

Human necessities

Electronic module for an inhaler and inhaler assembly comprising the electronic module

#60 | 2022-12-15 ✅ Patent 12,616,654 granted on 2026-05-05

US20220395454A1

Human necessities

STAINLESS STEEL CAN FOR PRESSURISED METERED DOSE INHALERS

#61 | 2022-11-03 ✅ Patent 11,981,639 granted on 2024-05-14

US20220348545A1

Chemistry; metallurgy

Process for the preparation of a PDE4 inhibitor

#62 | 2022-10-20 ✅ Patent 12,491,156 granted on 2025-12-09

US20220331244A1

Human necessities

NOVEL CARRIER PARTICLES FOR DRY POWDER FORMULATIONS FOR INHALATION

#63 | 2022-08-25 ✅ Patent 11,607,389 granted on 2023-03-21

US20220265559A1

Human necessities

Delayed release deferiprone tablets and methods of using the same

#64 | 2022-07-21 ✅ Patent 12,466,820 granted on 2025-11-11

US20220227749A1

Chemistry; metallurgy

AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS

#65 | 2022-07-14

US20220218678A1

Human necessities

USE OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES FOR TREATING CYSTIC FIBROSIS

#66 | 2022-06-09 ✅ Patent 12,527,797 granted on 2026-01-20

US20220175784A1

Human necessities

ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS

#67 | 2022-04-21

US20220117994A1

Human necessities

METHOD OF PREVENTING OF SYSTEMIC-TO-PULMONARY-ARTERY SHUNT THROMBOSIS

#68 | 2022-04-14 ✅ Patent 12,214,129 granted on 2025-02-04

US20220111168A1

Human necessities

Laryngeal mask airway device and method for administering a medicament through a laryngeal mask airway device

#69 | 2022-02-10

US20220040239A1

Human necessities

THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID FOR THE TREATMENT OF EVOLVING BPD

#70 | 2022-01-13

US20220008540A1

Human necessities

METHODS OF TREATING OR PREVENTING STENT THROMBOSIS

#71 | 2022-01-06

US20220000849A1

Human necessities

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING LOW IMPURITY CONCENTRATIONS OF THE SAME

#72 | 2021-12-16 ✅ Patent 11,723,874 granted on 2023-08-15

US20210386677A1

Human necessities

Delayed release deferiprone tablets and methods of using the same

#73 | 2021-12-02 ✅ Patent 12,097,329 granted on 2024-09-24

US20210370007A1

Human necessities

Apparatus to administer drugs to mechanically ventilated patients

#74 | 2021-09-23 ✅ Patent 11,813,360 granted on 2023-11-14

US20210290540A1

Human necessities

Carrier particles for dry powder formulations for inhalation

#75 | 2021-09-16

US20210284639A1

Chemistry; metallurgy

TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS

#76 | 2021-08-19

US20210253568A1

Chemistry; metallurgy

AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS

#77 | 2021-07-22 ✅ Patent 12,616,741 granted on 2026-05-05

US20210220445A1

Human necessities

THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID FOR THE PROPHYLAXIS OF BPD

#78 | 2021-06-17 ✅ Patent 11,628,175 granted on 2023-04-18

US20210177866A1

Human necessities

Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

#79 | 2021-03-18 ✅ Patent 12,378,293 granted on 2025-08-05

US20210079053A1

Chemistry; metallurgy

PRODUCTION OF NERVE GROWTH FACTOR (NGF) AND OF MUTEINS THEREOF

#80 | 2021-03-11 ✅ Patent 11,207,475 granted on 2021-12-28

US20210069431A1

Human necessities

Method and system for delivery of an aerosolized medicament

#81 | 2021-02-11 ✅ Patent 11,352,327 granted on 2022-06-07

US20210040040A1

Chemistry; metallurgy

Process for the preparation of a PDE4 inhibitor

#82 | 2021-02-11

US20210038575A1

Human necessities

USE OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES FOR TREATING CYSTIC FIBROSIS

#83 | 2021-01-28 ✅ Patent 11,147,812 granted on 2021-10-19

US20210023080A1

Human necessities

Tyrosine analogues derivatives as Rho-kinase inhibitors

#84 | 2021-01-21 ✅ Patent 11,510,934 granted on 2022-11-29

US20210015839A1

Human necessities

Maintenance of platelet inhibition during antiplatelet therapy

#85 | 2021-01-14 ✅ Patent 11,844,860 granted on 2023-12-19

US20210007984A1

Human necessities

Pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa

#86 | 2021-01-07 ✅ Patent 11,590,074 granted on 2023-02-28

US20210000738A1

Human necessities

Aerosol formulation for COPD

#87 | 2020-12-17 ✅ Patent 11,332,468 granted on 2022-05-17

US20200392133A1

Chemistry; metallurgy

Azaindole derivatives as Rho-kinase inhibitors

#88 | 2020-12-03 ✅ Patent 11,725,007 granted on 2023-08-15

US20200377500A1

Chemistry; metallurgy

Meta tyrosine derivatives as rho-kinase inhibitors

#89 | 2020-11-26 ✅ Patent 10,966,991 granted on 2021-04-06

US20200368252A1

Human necessities

Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

#90 | 2020-11-19 ✅ Patent 10,959,944 granted on 2021-03-30

US20200360278A1

Human necessities

Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

#91 | 2020-10-22 ✅ Patent 11,578,068 granted on 2023-02-14

US20200331912A1

Chemistry; metallurgy

Oxadiazole derivatives as Rho-Kinase Inhibitors

#92 | 2020-10-22

US20200330455A1

Human necessities

METHOD FOR TREATING NEONATAL OPIOD WITHDRAWAL SYNDROME

#93 | 2020-09-17 ✅ Patent 11,369,733 granted on 2022-06-28

US20200289742A1

Human necessities

System comprising a pre-fillable syringe and a package for the pre-fillable syringe

#94 | 2020-09-17 ✅ Patent 11,351,299 granted on 2022-06-07

US20200289741A1

Human necessities

System comprising a pre-fillable syringe and a package for the pre-fillable syringe

#95 | 2020-08-27 ✅ Patent 10,940,115 granted on 2021-03-09

US20200268672A1

Human necessities

Delayed release deferiprone tablets and methods of using the same

#96 | 2020-08-06

US20200246391A1

Human necessities

THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID FOR THE TREATMENT OF EVOLVING BPD

#97 | 2020-07-30 ✅ Patent 11,357,731 granted on 2022-06-14

US20200237674A1

Human necessities

Delayed release deferiprone tablets and methods of using the same

#98 | 2020-07-30

US20200237650A1

Human necessities

PHARMACEUTICAL FORMULATIONS COMPRISING OPIOID RECEPTOR AGONIST AS ACTIVE INGREDIENTS, METHODS OF MANUFACTURE AND THERAPEUTIC USES THEREOF

#99 | 2020-07-23 ✅ Patent 11,167,097 granted on 2021-11-09

US20200230331A9

Human necessities

Dry powder inhaler and inhalation actuated mechanism thereof

#100 | 2020-06-18 ✅ Patent 11,458,103 granted on 2022-10-04

US20200188309A1

Human necessities

Delayed release deferiprone tablets and methods of using the same

Also check out CHIESI FARMACEUTICI S.P.A.'s (Parma, Italy) applicant profile with 242 patent applications submitted.

AssigneeID:

1933 ⎘